Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

Discrimination of N2a and N2b by EBUS-TBNA: is a Needle Change Necessary? - a Prospective Pilot Study

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer

• indication for mediastinal staging

Locations
Other Locations
Austria
Medical University of Vienna
RECRUITING
Vienna
Contact Information
Primary
Daniela Gompelmann
daniela.gompelmann@meduniwien.ac.at
0043 1 40400 47730
Time Frame
Start Date: 2025-11-05
Estimated Completion Date: 2027-05
Participants
Target number of participants: 30
Treatments
Experimental: STudy group
Sponsors
Leads: University of Vienna

This content was sourced from clinicaltrials.gov